Ehninger, Neff and their coworkers through a thought-provoking paper claimed that rapamycin is capable of extending life span despite it having a limited effect on the aging process. The paper explained that this was possible as the process of aging is not reversible and can only be slowed down. The JCI paper demonstrated that rapamycin has the capability of slowing down the aging process thereby extending the lifespan of an individual despite its straightforward anti-cancer functions by Oncotarget. Aging has been found to be a MTOR-driven process in part, which is an aimless developmental growth continuation. According to research, rapamycin has been found to being capable of affecting similar processes in animals both old and young. It also affects young animal’s phenotypes and traits, which continuations later on become harmful, hyperfunctional and lastly lethal with time.
Plans for Oncology
Mikhail Blagosklonny is a professor, researcher and philanthropist who is determined to ensure that all people in the world get access to the best treatment they can possibly get irrespective of their financial status. Dr. Blagosklonny focuses specifically on the studies of both aging and cancer. He is particularly interested in finding the connection that exists between the two as well as the reasons why cancer is more prevalent in individuals at an advanced age. Dr. Blagosklonny is actively involved in research that will prove useful to the oncology field presently and in future. He is not only an influential person but also a great expert in this field who serves as an inspiration to both his peers as well as students looking forward to advance on his research.
Areas of His Research
Mikhail Blagosklonny has dwelled on certain topics on aging and cancer that have elicited a lot of attention in the medical field e.g. on impactjournals.com. He has set his goals on not only finding a way to cure cancer effectively but also in a manner that will not be as excruciating and costly as the processes available today. Mikhail is currently engaged in a study to find the best way of eliminating cancerous cells from the body without destroying or interfering with the normal cells. These normal cells play an important role in ensuring that the body and mind recover well after the long duration of cancer treatment.
Blagosklonny has so far managed to make great progress in the field and hopes that more students will be inspired to take over from him and continue his research. Mikhail Blagosklonny believes his works will serve as an inspiration to the new generation of researchers on tandfonline.com. He strongly believes that the treatment of cancer, a tragic and dangerous disease, will no longer be the luxury of a few moneyed individuals but for all persons regardless of their economical status.